Valeo Pharma (TSX:VPH) EV-to-Revenue : 1.21 (As of May. 22, 2024)

Valeo Pharma EV-to-Revenue Chart

Valeo Pharma Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EV-to-Revenue	Get a 7-Day Free Trial															2.80	2.11	1.58	1.33	1.58

Competitive Comparison of Valeo Pharma's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Valeo Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valeo Pharma's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valeo Pharma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Valeo Pharma's EV-to-Revenue falls into.

Valeo Pharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Valeo Pharma's EV-to-Revenue for today is calculated as:

Valeo Pharma's current Enterprise Value is C$65.53 Mil.
Valeo Pharma's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$54.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valeo Pharma  (TSX:VPH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Valeo Pharma's PS Ratiofor today is calculated as:

Valeo Pharma's share price for today is C$0.095.
Valeo Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.63.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valeo Pharma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Valeo Pharma (TSX:VPH) Business Description